Videos of all sessions can be viewed here.
Researchers and research participants across the country are facing big changes in the rules governing the ethical conduct of research. Many studies are affected, including those in basic science, biomedical research, the social sciences, and research with human participants. This conference featured senior leaders from the National Institutes of Health (NIH), Partners HealthCare, and Harvard University, who analyzed changes in oversight of emerging technologies, the Common Rule governing research with human participants, and the federal redefinition of “clinical trials” to cover more studies. Finally, a panel with community and local experts joined these speakers to debate the impact of these changes. This University of Minnesota Research Ethics Conference is especially valuable for researchers, clinicians, study coordinators, oversight personnel, research participants, patient advocates, students, and trainees.
Presented by the Office of the Vice President for Research; Consortium on Law and Values in Health, Environment & the Life Sciences; and Masonic Cancer Center, University of Minnesota
This conference is part of Research Ethics Week (March 4-8, 2019), during which the University of Minnesota focuses on professional development and best practices to ensure safety and integrity in research. To see a complete list of events being offered during Research Ethics Week, click here.
Disclosure information is available here.
Continuing Education Information:
To earn Continuing Education credits, webcast viewers must email us at email@example.com during the webcast to confirm their wish to receive CE credits. Later viewing of this video will not qualify for credit.
Attorneys: The Minnesota State Board of Continuing Legal Education approved 4.25 Continuing Legal Education (CLE) credits; Event Code is 268459.
Continuing Medical Education
In support of improving patient care, University of Minnesota, Interprofessional Continuing Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Designation Statements
American Medical Association (AMA)
The University of Minnesota, Interprofessional Continuing Education designates this live activity for a maximum of 4.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professionals
Other healthcare professionals who participate in this CE activity may submit their statement of participation to their appropriate accrediting organizations or state boards for consideration of credit. The participant is responsible for determining whether this activity meets the requirements for acceptable continuing education.
Educational Objectives for this conference are:
- Learn the content of the new guidelines and hear from experts about how they will influence research and clinical care, especially Institutional Biosafety Committees (IBCs) and the community.
- Gain an understanding of the ways the revised Common Rule will impact researchers, Institutional Review Boards (IRBs) and study participants.
- Researchers need to know how to mitigate the unintended consequences of the new NIH clinical trial rule, and apply the changes it specifies in their studies to stay in compliance